The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-((4-((3-((2-Methoxyethyl)amino)propyl)amino)-5-(triffuoromethyl)pyrimidin-2-yl)amino)picolinonitrile ID: ALA4861947
PubChem CID: 151426388
Max Phase: Preclinical
Molecular Formula: C17H20F3N7O
Molecular Weight: 395.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COCCNCCCNc1nc(Nc2ccc(C#N)nc2)ncc1C(F)(F)F
Standard InChI: InChI=1S/C17H20F3N7O/c1-28-8-7-22-5-2-6-23-15-14(17(18,19)20)11-25-16(27-15)26-13-4-3-12(9-21)24-10-13/h3-4,10-11,22H,2,5-8H2,1H3,(H2,23,25,26,27)
Standard InChI Key: PBPGYZNGDGRIDZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
11.0127 -25.1213 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.4294 -24.4087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6039 -24.4042 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.1446 -24.8170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1434 -25.6444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8583 -26.0615 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5747 -25.6439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5719 -24.8133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8565 -24.4084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2899 -26.0594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0036 -25.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7155 -26.0576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4287 -25.6406 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4279 -24.8146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7078 -24.4076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9974 -24.8188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4299 -23.5838 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.8540 -23.5834 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1381 -24.4065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8513 -23.9877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5672 -23.1687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2829 -23.5791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9962 -23.1645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7118 -23.5749 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4251 -23.1603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1409 -23.5705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8541 -23.1559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5698 -23.5663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
7 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
4 2 1 0
2 17 1 0
9 18 1 0
19 20 3 0
14 19 1 0
18 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 395.39Molecular Weight (Monoisotopic): 395.1681AlogP: 2.54#Rotatable Bonds: 10Polar Surface Area: 107.78Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.96CX Basic pKa: 9.59CX LogP: 1.40CX LogD: -0.38Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -1.50
References 1. Jin T, Xu L, Wang P, Hu X, Zhang R, Wu Z, Du W, Kan W, Li K, Wang C, Zhou Y, Li J, Liu T.. (2021) Discovery and Development of a Potent, Selective, and Orally Bioavailable CHK1 Inhibitor Candidate: 5-((4-((3-Amino-3-methylbutyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)picolinonitrile., 64 (20.0): [PMID:34665631 ] [10.1021/acs.jmedchem.1c00994 ]